Hemoccult® Products Hemoccult® Products
Our name is synonymous with fecal occult blood tests.

Most clinically proven
Trusted for over 30 years
Most widely used FOBT

The Hemoccult Test
 

The Hemoccult test is a rapid, convenient and qualitative method for detecting fecal occult blood which may be indicative of gastrointestinal disease.It is not a test for colorectal cancer or any other specific diseases.

The Hemoccult test is recommended for professional use as a diagnostic aid during routine physical examinations, for hospital patients to monitor for gastrointestinal bleeding, in patients with iron deficiency anemia or recuperating from surgery, peptic ulcer, ulcerative colitis and other conditions, and in screening programs for colorectal cancer when the Patient Instructions are closely followed.1,2

Supported by over 300 clinical studies

Built-in positive and negative analyte Performance Monitor

14 day on-slide stability

Comprehensive patient educational support

Clinically proven results
   

Product Effectiveness
 

Prospective, randomized controlled clinical trials extending for up to 18 years have demonstrated that the Hemoccult products are effective in detecting occult blood in stool as an early indication of colorectal cancer.

In clinical trials that enrolled over 339,000 individuals, mortality from colorectal cancer was reduced up to 33% when fecal occult blood tests were performed annually3-5 and 15-21% when performed biennially.6

The program sensitivity for detecting colorectal cancer when Hemoccult was performed annually was 90%.7,8
   

The Hemoccult Test consists of Two Main Components:
 

1.

Hemoccult or Hemoccult II Slides (Test Cards)
2.


 Hemoccult Developer, a developing solution containing a stabilized mixture of less than 5.0% hydrogen peroxide and 75% denatured ethyl alcohol in an aqueous solution.

   

Hemoccult Single Slides...
 

are convenient for use when single fecal specimens are collected for routine in-office gastrointestinal screening.
   

Hemoccult II Triple Slides...
 

are designed so patients can collect serial specimens at home from bowel movements over three days.

After the patient prepares the Hemoccult II test, it may be returned in person or by mail (using the Hemoccult Mailing Pouch) to the laboratory, hospital or medical office for developing and interpretation.

Polyps and cancer may bleed intermittently. Hemoccult II triple slides are designed so patients collect serial specimens over three days. This increases the probability of detecting hidden blood from polyps and cancer.

   

Hemoccult Product Links
 

Product Instructions (768k)

Configurations

Material Safety Data Sheets
   

Footnotes:

  1. Winawer, S.J., et al.: "Colorectal cancer screening: Clinical guidelines and rationale," Gastroenterol. 112:594-642, 1997.

2. Winawer, S.J., et al.: "Prevention of colorectal cancer: Guidelines based on new data," WHO Bulletin OMS. 73:7-10, 1995.

3. Hardcastle, J.D., et al.: "Randomised controlled trial of faecal-occult-blood screening for colorectal cancer," Lancet. 348:1471-1477, 1996.

4. Kronborg, O., et al.: "Randomised study of screening for colorectal cancer with faecal-occult-blood test," Lancet. 348:1467-1471, 1996.

5. Mandel, J.S., et al.:"Reducing mortality from colorectal cancer by screening for fecal occult blood," N Eng J Med. 328:1365-1371, 1993.

6. Mandel, J.S., et al.: "Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood," J Natl Cancer Inst. 91:434-437, 1999.

7. Ederer, F., et al.: "Fecal occult blood screening in the Minnesota Study: Role of chance detection of lesions," J Natl Cancer Inst. 89:1423-1428, 1997.

8. Church, T.R., et al.: "Fecal occult blood screening in the Minnesota Study: Sensitivity of the screening test," J Natl Cancer Inst. 91:1440-1448, 1997.